May 2024
Changes coming to coverage of some prescription drugs
Starting July 1, 2024, we’re changing how we cover some medications on the drug lists associated with our prescription drug plans. The following list detail these changes.
We’ll notify affected members, their groups and their health care providers in writing about the changes, see below for more information.
Drugs that will have a higher copayment
Unless noted, both the brand name and available generic equivalents of the following drugs won’t be covered. If a member fills a prescription for one of these drugs on or after July 1, 2024, they’ll be responsible for the full cost.
The brand-name drug that will have a higher copayment is listed along with suggested, covered preferred alternatives that have similar effectiveness, quality and safety. When pharmacies fill prescriptions with preferred alternatives, the generic equivalents are dispensed, if available. Additional coverage requirements may apply for preferred alternatives.
Drug that will have a higher copayment** |
Common use orÂ
drug class |
Preferred alternatives |
Ajovy® |
Migraine prevention |
Aimovig®, Emgality® 120mg/mL |
**Nonpreferred brand drugs are not covered for members with a closed benefit. |